CD38 Inhibitor 78c Attenuates Pro-Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages

William Lory, Nityananda Chowdhury, Bridgette Wellslager, Subramanya Pandruvada, Yan Huang, Özlem Yilmaz, Hong Yu, Alexander G Obukhov · 2024

Read CD38 Inhibitor 78c Attenuates Pro-Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages by William Lory, Nityananda Chowdhury, Bridgette Wellslager, Subramanya Pandruvada, Yan Huang, Özlem Yilmaz, Hong Yu, Alexander G Obukhov (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11640151.txt.

Description

William Lory and co-authors test an enzyme blocker against gum-driven inflammation in a 2024 study. CD38 is an enzyme that burns through NAD+, a molecule cells need for healthy work. Its levels rise during infection and inflammation, draining that supply.

The blocker 78c was fed to mouse macrophages in rising doses. It restored NAD+ levels and cut three flagship inflammatory signals. Two oral pathogens and aging-related compounds had provoked those signals. The drug also suppressed bone-eating cell formation driven by the RANKL signal. Blocking CD38 may calm both soft tissue and bone damage in gum disease.

Catalog record

CREATORWilliam Lory, Nityananda Chowdhury, Bridgette Wellslager, Subramanya Pandruvada, Yan Huang, Özlem Yilmaz, Hong Yu, Alexander G Obukhov
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11640151

Browse the full library · About the Tower of Babel